Global Somatostatin Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Somatostatin market size is predicted to grow from US$ 408 million in 2025 to US$ 798 million in 2031; it is expected to grow at a CAGR of 11.8% from 2025 to 2031.
Somatostatin is one kind of hormone. It is widely distributed throughout the body, especially in the hypothalamus and pancreas. It also acts as an important regulator of endocrine and nervous system function by inhibiting the secretion of several other hormones such as growth hormone, insulin, and gastrin.
Global Somatostatin key players include Merck (Schweiz) AG, SANOFI-AVENTIS FRANCE, Lyomark Pharma GmbH, ALFA WASSERMANN S.p.A., HYBIO, etc. Global top five manufacturers hold a share over 65%.
China is the largest market, followed by Europe and India.
LP Information, Inc. (LPI) ' newest research report, the “Somatostatin Industry Forecast” looks at past sales and reviews total world Somatostatin sales in 2024, providing a comprehensive analysis by region and market sector of projected Somatostatin sales for 2025 through 2031. With Somatostatin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Somatostatin industry.
This Insight Report provides a comprehensive analysis of the global Somatostatin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Somatostatin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Somatostatin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Somatostatin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Somatostatin.
This report presents a comprehensive overview, market shares, and growth opportunities of Somatostatin market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Somatostatin market?
What factors are driving Somatostatin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Somatostatin market opportunities vary by end market size?
How does Somatostatin break out by Type, by Application?
The global Somatostatin market size is predicted to grow from US$ 408 million in 2025 to US$ 798 million in 2031; it is expected to grow at a CAGR of 11.8% from 2025 to 2031.
Somatostatin is one kind of hormone. It is widely distributed throughout the body, especially in the hypothalamus and pancreas. It also acts as an important regulator of endocrine and nervous system function by inhibiting the secretion of several other hormones such as growth hormone, insulin, and gastrin.
Global Somatostatin key players include Merck (Schweiz) AG, SANOFI-AVENTIS FRANCE, Lyomark Pharma GmbH, ALFA WASSERMANN S.p.A., HYBIO, etc. Global top five manufacturers hold a share over 65%.
China is the largest market, followed by Europe and India.
LP Information, Inc. (LPI) ' newest research report, the “Somatostatin Industry Forecast” looks at past sales and reviews total world Somatostatin sales in 2024, providing a comprehensive analysis by region and market sector of projected Somatostatin sales for 2025 through 2031. With Somatostatin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Somatostatin industry.
This Insight Report provides a comprehensive analysis of the global Somatostatin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Somatostatin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Somatostatin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Somatostatin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Somatostatin.
This report presents a comprehensive overview, market shares, and growth opportunities of Somatostatin market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 0.25mg/pcs
- 0.75mg/pcs
- 3mg/pcs
- Hormonal Disorder
- Oncology
- Metabolic Disorder
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck (Schweiz) AG
- SANOFI-AVENTIS FRANCE
- Lyomark Pharma GmbH
- ALFA WASSERMANN S.p.A.
- Polypeptide Laboratories, Inc
- SAMARTH
- UBPL
- HYBIO
- TianTaiShan
- Yangtze River
- Siyao
- Shuangcheng
- Hainan Zhonghe
- SL PHARM
- Wuhan Hualong
- Qingdao Guoda
- Chengdu Shengnuo
- Longjin
What is the 10-year outlook for the global Somatostatin market?
What factors are driving Somatostatin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Somatostatin market opportunities vary by end market size?
How does Somatostatin break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Somatostatin Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Somatostatin by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Somatostatin by Country/Region, 2020, 2024 & 2031
2.2 Somatostatin Segment by Type
2.2.1 0.25mg/pcs
2.2.2 0.75mg/pcs
2.2.3 3mg/pcs
2.3 Somatostatin Sales by Type
2.3.1 Global Somatostatin Sales Market Share by Type (2020-2025)
2.3.2 Global Somatostatin Revenue and Market Share by Type (2020-2025)
2.3.3 Global Somatostatin Sale Price by Type (2020-2025)
2.4 Somatostatin Segment by Application
2.4.1 Hormonal Disorder
2.4.2 Oncology
2.4.3 Metabolic Disorder
2.4.4 Others
2.5 Somatostatin Sales by Application
2.5.1 Global Somatostatin Sale Market Share by Application (2020-2025)
2.5.2 Global Somatostatin Revenue and Market Share by Application (2020-2025)
2.5.3 Global Somatostatin Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Somatostatin Breakdown Data by Company
3.1.1 Global Somatostatin Annual Sales by Company (2020-2025)
3.1.2 Global Somatostatin Sales Market Share by Company (2020-2025)
3.2 Global Somatostatin Annual Revenue by Company (2020-2025)
3.2.1 Global Somatostatin Revenue by Company (2020-2025)
3.2.2 Global Somatostatin Revenue Market Share by Company (2020-2025)
3.3 Global Somatostatin Sale Price by Company
3.4 Key Manufacturers Somatostatin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Somatostatin Product Location Distribution
3.4.2 Players Somatostatin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR SOMATOSTATIN BY GEOGRAPHIC REGION
4.1 World Historic Somatostatin Market Size by Geographic Region (2020-2025)
4.1.1 Global Somatostatin Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Somatostatin Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Somatostatin Market Size by Country/Region (2020-2025)
4.2.1 Global Somatostatin Annual Sales by Country/Region (2020-2025)
4.2.2 Global Somatostatin Annual Revenue by Country/Region (2020-2025)
4.3 Americas Somatostatin Sales Growth
4.4 APAC Somatostatin Sales Growth
4.5 Europe Somatostatin Sales Growth
4.6 Middle East & Africa Somatostatin Sales Growth
5 AMERICAS
5.1 Americas Somatostatin Sales by Country
5.1.1 Americas Somatostatin Sales by Country (2020-2025)
5.1.2 Americas Somatostatin Revenue by Country (2020-2025)
5.2 Americas Somatostatin Sales by Type (2020-2025)
5.3 Americas Somatostatin Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Somatostatin Sales by Region
6.1.1 APAC Somatostatin Sales by Region (2020-2025)
6.1.2 APAC Somatostatin Revenue by Region (2020-2025)
6.2 APAC Somatostatin Sales by Type (2020-2025)
6.3 APAC Somatostatin Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Somatostatin by Country
7.1.1 Europe Somatostatin Sales by Country (2020-2025)
7.1.2 Europe Somatostatin Revenue by Country (2020-2025)
7.2 Europe Somatostatin Sales by Type (2020-2025)
7.3 Europe Somatostatin Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Somatostatin by Country
8.1.1 Middle East & Africa Somatostatin Sales by Country (2020-2025)
8.1.2 Middle East & Africa Somatostatin Revenue by Country (2020-2025)
8.2 Middle East & Africa Somatostatin Sales by Type (2020-2025)
8.3 Middle East & Africa Somatostatin Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Somatostatin
10.3 Manufacturing Process Analysis of Somatostatin
10.4 Industry Chain Structure of Somatostatin
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Somatostatin Distributors
11.3 Somatostatin Customer
12 WORLD FORECAST REVIEW FOR SOMATOSTATIN BY GEOGRAPHIC REGION
12.1 Global Somatostatin Market Size Forecast by Region
12.1.1 Global Somatostatin Forecast by Region (2026-2031)
12.1.2 Global Somatostatin Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Somatostatin Forecast by Type (2026-2031)
12.7 Global Somatostatin Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Merck (Schweiz) AG
13.1.1 Merck (Schweiz) AG Company Information
13.1.2 Merck (Schweiz) AG Somatostatin Product Portfolios and Specifications
13.1.3 Merck (Schweiz) AG Somatostatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Merck (Schweiz) AG Main Business Overview
13.1.5 Merck (Schweiz) AG Latest Developments
13.2 SANOFI-AVENTIS FRANCE
13.2.1 SANOFI-AVENTIS FRANCE Company Information
13.2.2 SANOFI-AVENTIS FRANCE Somatostatin Product Portfolios and Specifications
13.2.3 SANOFI-AVENTIS FRANCE Somatostatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 SANOFI-AVENTIS FRANCE Main Business Overview
13.2.5 SANOFI-AVENTIS FRANCE Latest Developments
13.3 Lyomark Pharma GmbH
13.3.1 Lyomark Pharma GmbH Company Information
13.3.2 Lyomark Pharma GmbH Somatostatin Product Portfolios and Specifications
13.3.3 Lyomark Pharma GmbH Somatostatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Lyomark Pharma GmbH Main Business Overview
13.3.5 Lyomark Pharma GmbH Latest Developments
13.4 ALFA WASSERMANN S.p.A.
13.4.1 ALFA WASSERMANN S.p.A. Company Information
13.4.2 ALFA WASSERMANN S.p.A. Somatostatin Product Portfolios and Specifications
13.4.3 ALFA WASSERMANN S.p.A. Somatostatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 ALFA WASSERMANN S.p.A. Main Business Overview
13.4.5 ALFA WASSERMANN S.p.A. Latest Developments
13.5 Polypeptide Laboratories, Inc
13.5.1 Polypeptide Laboratories, Inc Company Information
13.5.2 Polypeptide Laboratories, Inc Somatostatin Product Portfolios and Specifications
13.5.3 Polypeptide Laboratories, Inc Somatostatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Polypeptide Laboratories, Inc Main Business Overview
13.5.5 Polypeptide Laboratories, Inc Latest Developments
13.6 SAMARTH
13.6.1 SAMARTH Company Information
13.6.2 SAMARTH Somatostatin Product Portfolios and Specifications
13.6.3 SAMARTH Somatostatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 SAMARTH Main Business Overview
13.6.5 SAMARTH Latest Developments
13.7 UBPL
13.7.1 UBPL Company Information
13.7.2 UBPL Somatostatin Product Portfolios and Specifications
13.7.3 UBPL Somatostatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 UBPL Main Business Overview
13.7.5 UBPL Latest Developments
13.8 HYBIO
13.8.1 HYBIO Company Information
13.8.2 HYBIO Somatostatin Product Portfolios and Specifications
13.8.3 HYBIO Somatostatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 HYBIO Main Business Overview
13.8.5 HYBIO Latest Developments
13.9 TianTaiShan
13.9.1 TianTaiShan Company Information
13.9.2 TianTaiShan Somatostatin Product Portfolios and Specifications
13.9.3 TianTaiShan Somatostatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 TianTaiShan Main Business Overview
13.9.5 TianTaiShan Latest Developments
13.10 Yangtze River
13.10.1 Yangtze River Company Information
13.10.2 Yangtze River Somatostatin Product Portfolios and Specifications
13.10.3 Yangtze River Somatostatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Yangtze River Main Business Overview
13.10.5 Yangtze River Latest Developments
13.11 Siyao
13.11.1 Siyao Company Information
13.11.2 Siyao Somatostatin Product Portfolios and Specifications
13.11.3 Siyao Somatostatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Siyao Main Business Overview
13.11.5 Siyao Latest Developments
13.12 Shuangcheng
13.12.1 Shuangcheng Company Information
13.12.2 Shuangcheng Somatostatin Product Portfolios and Specifications
13.12.3 Shuangcheng Somatostatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Shuangcheng Main Business Overview
13.12.5 Shuangcheng Latest Developments
13.13 Hainan Zhonghe
13.13.1 Hainan Zhonghe Company Information
13.13.2 Hainan Zhonghe Somatostatin Product Portfolios and Specifications
13.13.3 Hainan Zhonghe Somatostatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Hainan Zhonghe Main Business Overview
13.13.5 Hainan Zhonghe Latest Developments
13.14 SL PHARM
13.14.1 SL PHARM Company Information
13.14.2 SL PHARM Somatostatin Product Portfolios and Specifications
13.14.3 SL PHARM Somatostatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 SL PHARM Main Business Overview
13.14.5 SL PHARM Latest Developments
13.15 Wuhan Hualong
13.15.1 Wuhan Hualong Company Information
13.15.2 Wuhan Hualong Somatostatin Product Portfolios and Specifications
13.15.3 Wuhan Hualong Somatostatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Wuhan Hualong Main Business Overview
13.15.5 Wuhan Hualong Latest Developments
13.16 Qingdao Guoda
13.16.1 Qingdao Guoda Company Information
13.16.2 Qingdao Guoda Somatostatin Product Portfolios and Specifications
13.16.3 Qingdao Guoda Somatostatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Qingdao Guoda Main Business Overview
13.16.5 Qingdao Guoda Latest Developments
13.17 Chengdu Shengnuo
13.17.1 Chengdu Shengnuo Company Information
13.17.2 Chengdu Shengnuo Somatostatin Product Portfolios and Specifications
13.17.3 Chengdu Shengnuo Somatostatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Chengdu Shengnuo Main Business Overview
13.17.5 Chengdu Shengnuo Latest Developments
13.18 Longjin
13.18.1 Longjin Company Information
13.18.2 Longjin Somatostatin Product Portfolios and Specifications
13.18.3 Longjin Somatostatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 Longjin Main Business Overview
13.18.5 Longjin Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Somatostatin Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Somatostatin Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 0.25mg/pcs
Table 4. Major Players of 0.75mg/pcs
Table 5. Major Players of 3mg/pcs
Table 6. Global Somatostatin Sales byType (2020-2025) & (K Pcs)
Table 7. Global Somatostatin Sales Market Share byType (2020-2025)
Table 8. Global Somatostatin Revenue byType (2020-2025) & ($ million)
Table 9. Global Somatostatin Revenue Market Share byType (2020-2025)
Table 10. Global Somatostatin Sale Price byType (2020-2025) & (USD/Pcs)
Table 11. Global Somatostatin Sale by Application (2020-2025) & (K Pcs)
Table 12. Global Somatostatin Sale Market Share by Application (2020-2025)
Table 13. Global Somatostatin Revenue by Application (2020-2025) & ($ million)
Table 14. Global Somatostatin Revenue Market Share by Application (2020-2025)
Table 15. Global Somatostatin Sale Price by Application (2020-2025) & (USD/Pcs)
Table 16. Global Somatostatin Sales by Company (2020-2025) & (K Pcs)
Table 17. Global Somatostatin Sales Market Share by Company (2020-2025)
Table 18. Global Somatostatin Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Somatostatin Revenue Market Share by Company (2020-2025)
Table 20. Global Somatostatin Sale Price by Company (2020-2025) & (USD/Pcs)
Table 21. Key Manufacturers Somatostatin Producing Area Distribution and Sales Area
Table 22. Players Somatostatin Products Offered
Table 23. Somatostatin Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Somatostatin Sales by Geographic Region (2020-2025) & (K Pcs)
Table 27. Global Somatostatin Sales Market Share Geographic Region (2020-2025)
Table 28. Global Somatostatin Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Somatostatin Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Somatostatin Sales by Country/Region (2020-2025) & (K Pcs)
Table 31. Global Somatostatin Sales Market Share by Country/Region (2020-2025)
Table 32. Global Somatostatin Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Somatostatin Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Somatostatin Sales by Country (2020-2025) & (K Pcs)
Table 35. Americas Somatostatin Sales Market Share by Country (2020-2025)
Table 36. Americas Somatostatin Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Somatostatin Sales byType (2020-2025) & (K Pcs)
Table 38. Americas Somatostatin Sales by Application (2020-2025) & (K Pcs)
Table 39. APAC Somatostatin Sales by Region (2020-2025) & (K Pcs)
Table 40. APAC Somatostatin Sales Market Share by Region (2020-2025)
Table 41. APAC Somatostatin Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Somatostatin Sales byType (2020-2025) & (K Pcs)
Table 43. APAC Somatostatin Sales by Application (2020-2025) & (K Pcs)
Table 44. Europe Somatostatin Sales by Country (2020-2025) & (K Pcs)
Table 45. Europe Somatostatin Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Somatostatin Sales byType (2020-2025) & (K Pcs)
Table 47. Europe Somatostatin Sales by Application (2020-2025) & (K Pcs)
Table 48. Middle East & Africa Somatostatin Sales by Country (2020-2025) & (K Pcs)
Table 49. Middle East & Africa Somatostatin Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Somatostatin Sales byType (2020-2025) & (K Pcs)
Table 51. Middle East & Africa Somatostatin Sales by Application (2020-2025) & (K Pcs)
Table 52. Key Market Drivers & Growth Opportunities of Somatostatin
Table 53. Key Market Challenges & Risks of Somatostatin
Table 54. Key IndustryTrends of Somatostatin
Table 55. Somatostatin Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Somatostatin Distributors List
Table 58. Somatostatin Customer List
Table 59. Global Somatostatin SalesForecast by Region (2026-2031) & (K Pcs)
Table 60. Global Somatostatin RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. Americas Somatostatin SalesForecast by Country (2026-2031) & (K Pcs)
Table 62. Americas Somatostatin Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APAC Somatostatin SalesForecast by Region (2026-2031) & (K Pcs)
Table 64. APAC Somatostatin Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. Europe Somatostatin SalesForecast by Country (2026-2031) & (K Pcs)
Table 66. Europe Somatostatin RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Somatostatin SalesForecast by Country (2026-2031) & (K Pcs)
Table 68. Middle East & Africa Somatostatin RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Global Somatostatin SalesForecast byType (2026-2031) & (K Pcs)
Table 70. Global Somatostatin RevenueForecast byType (2026-2031) & ($ millions)
Table 71. Global Somatostatin SalesForecast by Application (2026-2031) & (K Pcs)
Table 72. Global Somatostatin RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. Merck (Schweiz) AG Basic Information, Somatostatin Manufacturing Base, Sales Area and Its Competitors
Table 74. Merck (Schweiz) AG Somatostatin Product Portfolios and Specifications
Table 75. Merck (Schweiz) AG Somatostatin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 76. Merck (Schweiz) AG Main Business
Table 77. Merck (Schweiz) AG Latest Developments
Table 78. SANOFI-AVENTISFRANCE Basic Information, Somatostatin Manufacturing Base, Sales Area and Its Competitors
Table 79. SANOFI-AVENTISFRANCE Somatostatin Product Portfolios and Specifications
Table 80. SANOFI-AVENTISFRANCE Somatostatin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 81. SANOFI-AVENTISFRANCE Main Business
Table 82. SANOFI-AVENTISFRANCE Latest Developments
Table 83. Lyomark Pharma GmbH Basic Information, Somatostatin Manufacturing Base, Sales Area and Its Competitors
Table 84. Lyomark Pharma GmbH Somatostatin Product Portfolios and Specifications
Table 85. Lyomark Pharma GmbH Somatostatin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 86. Lyomark Pharma GmbH Main Business
Table 87. Lyomark Pharma GmbH Latest Developments
Table 88. ALFA WASSERMANN S.p.A. Basic Information, Somatostatin Manufacturing Base, Sales Area and Its Competitors
Table 89. ALFA WASSERMANN S.p.A. Somatostatin Product Portfolios and Specifications
Table 90. ALFA WASSERMANN S.p.A. Somatostatin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 91. ALFA WASSERMANN S.p.A. Main Business
Table 92. ALFA WASSERMANN S.p.A. Latest Developments
Table 93. Polypeptide Laboratories, Inc Basic Information, Somatostatin Manufacturing Base, Sales Area and Its Competitors
Table 94. Polypeptide Laboratories, Inc Somatostatin Product Portfolios and Specifications
Table 95. Polypeptide Laboratories, Inc Somatostatin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 96. Polypeptide Laboratories, Inc Main Business
Table 97. Polypeptide Laboratories, Inc Latest Developments
Table 98. SAMARTH Basic Information, Somatostatin Manufacturing Base, Sales Area and Its Competitors
Table 99. SAMARTH Somatostatin Product Portfolios and Specifications
Table 100. SAMARTH Somatostatin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 101. SAMARTH Main Business
Table 102. SAMARTH Latest Developments
Table 103. UBPL Basic Information, Somatostatin Manufacturing Base, Sales Area and Its Competitors
Table 104. UBPL Somatostatin Product Portfolios and Specifications
Table 105. UBPL Somatostatin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 106. UBPL Main Business
Table 107. UBPL Latest Developments
Table 108. HYBIO Basic Information, Somatostatin Manufacturing Base, Sales Area and Its Competitors
Table 109. HYBIO Somatostatin Product Portfolios and Specifications
Table 110. HYBIO Somatostatin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 111. HYBIO Main Business
Table 112. HYBIO Latest Developments
Table 113.TianTaiShan Basic Information, Somatostatin Manufacturing Base, Sales Area and Its Competitors
Table 114.TianTaiShan Somatostatin Product Portfolios and Specifications
Table 115.TianTaiShan Somatostatin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 116.TianTaiShan Main Business
Table 117.TianTaiShan Latest Developments
Table 118. Yangtze River Basic Information, Somatostatin Manufacturing Base, Sales Area and Its Competitors
Table 119. Yangtze River Somatostatin Product Portfolios and Specifications
Table 120. Yangtze River Somatostatin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 121. Yangtze River Main Business
Table 122. Yangtze River Latest Developments
Table 123. Siyao Basic Information, Somatostatin Manufacturing Base, Sales Area and Its Competitors
Table 124. Siyao Somatostatin Product Portfolios and Specifications
Table 125. Siyao Somatostatin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 126. Siyao Main Business
Table 127. Siyao Latest Developments
Table 128. Shuangcheng Basic Information, Somatostatin Manufacturing Base, Sales Area and Its Competitors
Table 129. Shuangcheng Somatostatin Product Portfolios and Specifications
Table 130. Shuangcheng Somatostatin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 131. Shuangcheng Main Business
Table 132. Shuangcheng Latest Developments
Table 133. Hainan Zhonghe Basic Information, Somatostatin Manufacturing Base, Sales Area and Its Competitors
Table 134. Hainan Zhonghe Somatostatin Product Portfolios and Specifications
Table 135. Hainan Zhonghe Somatostatin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 136. Hainan Zhonghe Main Business
Table 137. Hainan Zhonghe Latest Developments
Table 138. SL PHARM Basic Information, Somatostatin Manufacturing Base, Sales Area and Its Competitors
Table 139. SL PHARM Somatostatin Product Portfolios and Specifications
Table 140. SL PHARM Somatostatin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 141. SL PHARM Main Business
Table 142. SL PHARM Latest Developments
Table 143. Wuhan Hualong Basic Information, Somatostatin Manufacturing Base, Sales Area and Its Competitors
Table 144. Wuhan Hualong Somatostatin Product Portfolios and Specifications
Table 145. Wuhan Hualong Somatostatin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 146. Wuhan Hualong Main Business
Table 147. Wuhan Hualong Latest Developments
Table 148. Qingdao Guoda Basic Information, Somatostatin Manufacturing Base, Sales Area and Its Competitors
Table 149. Qingdao Guoda Somatostatin Product Portfolios and Specifications
Table 150. Qingdao Guoda Somatostatin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 151. Qingdao Guoda Main Business
Table 152. Qingdao Guoda Latest Developments
Table 153. Chengdu Shengnuo Basic Information, Somatostatin Manufacturing Base, Sales Area and Its Competitors
Table 154. Chengdu Shengnuo Somatostatin Product Portfolios and Specifications
Table 155. Chengdu Shengnuo Somatostatin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 156. Chengdu Shengnuo Main Business
Table 157. Chengdu Shengnuo Latest Developments
Table 158. Longjin Basic Information, Somatostatin Manufacturing Base, Sales Area and Its Competitors
Table 159. Longjin Somatostatin Product Portfolios and Specifications
Table 160. Longjin Somatostatin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 161. Longjin Main Business
Table 162. Longjin Latest Developments
LIST OFFIGURES
Figure 1. Picture of Somatostatin
Figure 2. Somatostatin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Somatostatin Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Somatostatin Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Somatostatin Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Somatostatin Sales Market Share by Country/Region (2024)
Figure 10. Somatostatin Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 0.25mg/pcs
Figure 12. Product Picture of 0.75mg/pcs
Figure 13. Product Picture of 3mg/pcs
Figure 14. Global Somatostatin Sales Market Share byType in 2025
Figure 15. Global Somatostatin Revenue Market Share byType (2020-2025)
Figure 16. Somatostatin Consumed in Hormonal Disorder
Figure 17. Global Somatostatin Market: Hormonal Disorder (2020-2025) & (K Pcs)
Figure 18. Somatostatin Consumed in Oncology
Figure 19. Global Somatostatin Market: Oncology (2020-2025) & (K Pcs)
Figure 20. Somatostatin Consumed in Metabolic Disorder
Figure 21. Global Somatostatin Market: Metabolic Disorder (2020-2025) & (K Pcs)
Figure 22. Somatostatin Consumed in Others
Figure 23. Global Somatostatin Market: Others (2020-2025) & (K Pcs)
Figure 24. Global Somatostatin Sale Market Share by Application (2024)
Figure 25. Global Somatostatin Revenue Market Share by Application in 2025
Figure 26. Somatostatin Sales by Company in 2025 (K Pcs)
Figure 27. Global Somatostatin Sales Market Share by Company in 2025
Figure 28. Somatostatin Revenue by Company in 2025 ($ millions)
Figure 29. Global Somatostatin Revenue Market Share by Company in 2025
Figure 30. Global Somatostatin Sales Market Share by Geographic Region (2020-2025)
Figure 31. Global Somatostatin Revenue Market Share by Geographic Region in 2025
Figure 32. Americas Somatostatin Sales 2020-2025 (K Pcs)
Figure 33. Americas Somatostatin Revenue 2020-2025 ($ millions)
Figure 34. APAC Somatostatin Sales 2020-2025 (K Pcs)
Figure 35. APAC Somatostatin Revenue 2020-2025 ($ millions)
Figure 36. Europe Somatostatin Sales 2020-2025 (K Pcs)
Figure 37. Europe Somatostatin Revenue 2020-2025 ($ millions)
Figure 38. Middle East & Africa Somatostatin Sales 2020-2025 (K Pcs)
Figure 39. Middle East & Africa Somatostatin Revenue 2020-2025 ($ millions)
Figure 40. Americas Somatostatin Sales Market Share by Country in 2025
Figure 41. Americas Somatostatin Revenue Market Share by Country (2020-2025)
Figure 42. Americas Somatostatin Sales Market Share byType (2020-2025)
Figure 43. Americas Somatostatin Sales Market Share by Application (2020-2025)
Figure 44. United States Somatostatin Revenue Growth 2020-2025 ($ millions)
Figure 45. Canada Somatostatin Revenue Growth 2020-2025 ($ millions)
Figure 46. Mexico Somatostatin Revenue Growth 2020-2025 ($ millions)
Figure 47. Brazil Somatostatin Revenue Growth 2020-2025 ($ millions)
Figure 48. APAC Somatostatin Sales Market Share by Region in 2025
Figure 49. APAC Somatostatin Revenue Market Share by Region (2020-2025)
Figure 50. APAC Somatostatin Sales Market Share byType (2020-2025)
Figure 51. APAC Somatostatin Sales Market Share by Application (2020-2025)
Figure 52. China Somatostatin Revenue Growth 2020-2025 ($ millions)
Figure 53. Japan Somatostatin Revenue Growth 2020-2025 ($ millions)
Figure 54. South Korea Somatostatin Revenue Growth 2020-2025 ($ millions)
Figure 55. Southeast Asia Somatostatin Revenue Growth 2020-2025 ($ millions)
Figure 56. India Somatostatin Revenue Growth 2020-2025 ($ millions)
Figure 57. Australia Somatostatin Revenue Growth 2020-2025 ($ millions)
Figure 58. ChinaTaiwan Somatostatin Revenue Growth 2020-2025 ($ millions)
Figure 59. Europe Somatostatin Sales Market Share by Country in 2025
Figure 60. Europe Somatostatin Revenue Market Share by Country (2020-2025)
Figure 61. Europe Somatostatin Sales Market Share byType (2020-2025)
Figure 62. Europe Somatostatin Sales Market Share by Application (2020-2025)
Figure 63. Germany Somatostatin Revenue Growth 2020-2025 ($ millions)
Figure 64.France Somatostatin Revenue Growth 2020-2025 ($ millions)
Figure 65. UK Somatostatin Revenue Growth 2020-2025 ($ millions)
Figure 66. Italy Somatostatin Revenue Growth 2020-2025 ($ millions)
Figure 67. Russia Somatostatin Revenue Growth 2020-2025 ($ millions)
Figure 68. Middle East & Africa Somatostatin Sales Market Share by Country (2020-2025)
Figure 69. Middle East & Africa Somatostatin Sales Market Share byType (2020-2025)
Figure 70. Middle East & Africa Somatostatin Sales Market Share by Application (2020-2025)
Figure 71. Egypt Somatostatin Revenue Growth 2020-2025 ($ millions)
Figure 72. South Africa Somatostatin Revenue Growth 2020-2025 ($ millions)
Figure 73. Israel Somatostatin Revenue Growth 2020-2025 ($ millions)
Figure 74.Turkey Somatostatin Revenue Growth 2020-2025 ($ millions)
Figure 75. GCC Countries Somatostatin Revenue Growth 2020-2025 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Somatostatin in 2025
Figure 77. Manufacturing Process Analysis of Somatostatin
Figure 78. Industry Chain Structure of Somatostatin
Figure 79. Channels of Distribution
Figure 80. Global Somatostatin Sales MarketForecast by Region (2026-2031)
Figure 81. Global Somatostatin Revenue Market ShareForecast by Region (2026-2031)
Figure 82. Global Somatostatin Sales Market ShareForecast byType (2026-2031)
Figure 83. Global Somatostatin Revenue Market ShareForecast byType (2026-2031)
Figure 84. Global Somatostatin Sales Market ShareForecast by Application (2026-2031)
Figure 85. Global Somatostatin Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Somatostatin Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Somatostatin by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Somatostatin by Country/Region, 2020, 2024 & 2031
2.2 Somatostatin Segment by Type
2.2.1 0.25mg/pcs
2.2.2 0.75mg/pcs
2.2.3 3mg/pcs
2.3 Somatostatin Sales by Type
2.3.1 Global Somatostatin Sales Market Share by Type (2020-2025)
2.3.2 Global Somatostatin Revenue and Market Share by Type (2020-2025)
2.3.3 Global Somatostatin Sale Price by Type (2020-2025)
2.4 Somatostatin Segment by Application
2.4.1 Hormonal Disorder
2.4.2 Oncology
2.4.3 Metabolic Disorder
2.4.4 Others
2.5 Somatostatin Sales by Application
2.5.1 Global Somatostatin Sale Market Share by Application (2020-2025)
2.5.2 Global Somatostatin Revenue and Market Share by Application (2020-2025)
2.5.3 Global Somatostatin Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Somatostatin Breakdown Data by Company
3.1.1 Global Somatostatin Annual Sales by Company (2020-2025)
3.1.2 Global Somatostatin Sales Market Share by Company (2020-2025)
3.2 Global Somatostatin Annual Revenue by Company (2020-2025)
3.2.1 Global Somatostatin Revenue by Company (2020-2025)
3.2.2 Global Somatostatin Revenue Market Share by Company (2020-2025)
3.3 Global Somatostatin Sale Price by Company
3.4 Key Manufacturers Somatostatin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Somatostatin Product Location Distribution
3.4.2 Players Somatostatin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR SOMATOSTATIN BY GEOGRAPHIC REGION
4.1 World Historic Somatostatin Market Size by Geographic Region (2020-2025)
4.1.1 Global Somatostatin Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Somatostatin Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Somatostatin Market Size by Country/Region (2020-2025)
4.2.1 Global Somatostatin Annual Sales by Country/Region (2020-2025)
4.2.2 Global Somatostatin Annual Revenue by Country/Region (2020-2025)
4.3 Americas Somatostatin Sales Growth
4.4 APAC Somatostatin Sales Growth
4.5 Europe Somatostatin Sales Growth
4.6 Middle East & Africa Somatostatin Sales Growth
5 AMERICAS
5.1 Americas Somatostatin Sales by Country
5.1.1 Americas Somatostatin Sales by Country (2020-2025)
5.1.2 Americas Somatostatin Revenue by Country (2020-2025)
5.2 Americas Somatostatin Sales by Type (2020-2025)
5.3 Americas Somatostatin Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Somatostatin Sales by Region
6.1.1 APAC Somatostatin Sales by Region (2020-2025)
6.1.2 APAC Somatostatin Revenue by Region (2020-2025)
6.2 APAC Somatostatin Sales by Type (2020-2025)
6.3 APAC Somatostatin Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Somatostatin by Country
7.1.1 Europe Somatostatin Sales by Country (2020-2025)
7.1.2 Europe Somatostatin Revenue by Country (2020-2025)
7.2 Europe Somatostatin Sales by Type (2020-2025)
7.3 Europe Somatostatin Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Somatostatin by Country
8.1.1 Middle East & Africa Somatostatin Sales by Country (2020-2025)
8.1.2 Middle East & Africa Somatostatin Revenue by Country (2020-2025)
8.2 Middle East & Africa Somatostatin Sales by Type (2020-2025)
8.3 Middle East & Africa Somatostatin Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Somatostatin
10.3 Manufacturing Process Analysis of Somatostatin
10.4 Industry Chain Structure of Somatostatin
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Somatostatin Distributors
11.3 Somatostatin Customer
12 WORLD FORECAST REVIEW FOR SOMATOSTATIN BY GEOGRAPHIC REGION
12.1 Global Somatostatin Market Size Forecast by Region
12.1.1 Global Somatostatin Forecast by Region (2026-2031)
12.1.2 Global Somatostatin Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Somatostatin Forecast by Type (2026-2031)
12.7 Global Somatostatin Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Merck (Schweiz) AG
13.1.1 Merck (Schweiz) AG Company Information
13.1.2 Merck (Schweiz) AG Somatostatin Product Portfolios and Specifications
13.1.3 Merck (Schweiz) AG Somatostatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Merck (Schweiz) AG Main Business Overview
13.1.5 Merck (Schweiz) AG Latest Developments
13.2 SANOFI-AVENTIS FRANCE
13.2.1 SANOFI-AVENTIS FRANCE Company Information
13.2.2 SANOFI-AVENTIS FRANCE Somatostatin Product Portfolios and Specifications
13.2.3 SANOFI-AVENTIS FRANCE Somatostatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 SANOFI-AVENTIS FRANCE Main Business Overview
13.2.5 SANOFI-AVENTIS FRANCE Latest Developments
13.3 Lyomark Pharma GmbH
13.3.1 Lyomark Pharma GmbH Company Information
13.3.2 Lyomark Pharma GmbH Somatostatin Product Portfolios and Specifications
13.3.3 Lyomark Pharma GmbH Somatostatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Lyomark Pharma GmbH Main Business Overview
13.3.5 Lyomark Pharma GmbH Latest Developments
13.4 ALFA WASSERMANN S.p.A.
13.4.1 ALFA WASSERMANN S.p.A. Company Information
13.4.2 ALFA WASSERMANN S.p.A. Somatostatin Product Portfolios and Specifications
13.4.3 ALFA WASSERMANN S.p.A. Somatostatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 ALFA WASSERMANN S.p.A. Main Business Overview
13.4.5 ALFA WASSERMANN S.p.A. Latest Developments
13.5 Polypeptide Laboratories, Inc
13.5.1 Polypeptide Laboratories, Inc Company Information
13.5.2 Polypeptide Laboratories, Inc Somatostatin Product Portfolios and Specifications
13.5.3 Polypeptide Laboratories, Inc Somatostatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Polypeptide Laboratories, Inc Main Business Overview
13.5.5 Polypeptide Laboratories, Inc Latest Developments
13.6 SAMARTH
13.6.1 SAMARTH Company Information
13.6.2 SAMARTH Somatostatin Product Portfolios and Specifications
13.6.3 SAMARTH Somatostatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 SAMARTH Main Business Overview
13.6.5 SAMARTH Latest Developments
13.7 UBPL
13.7.1 UBPL Company Information
13.7.2 UBPL Somatostatin Product Portfolios and Specifications
13.7.3 UBPL Somatostatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 UBPL Main Business Overview
13.7.5 UBPL Latest Developments
13.8 HYBIO
13.8.1 HYBIO Company Information
13.8.2 HYBIO Somatostatin Product Portfolios and Specifications
13.8.3 HYBIO Somatostatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 HYBIO Main Business Overview
13.8.5 HYBIO Latest Developments
13.9 TianTaiShan
13.9.1 TianTaiShan Company Information
13.9.2 TianTaiShan Somatostatin Product Portfolios and Specifications
13.9.3 TianTaiShan Somatostatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 TianTaiShan Main Business Overview
13.9.5 TianTaiShan Latest Developments
13.10 Yangtze River
13.10.1 Yangtze River Company Information
13.10.2 Yangtze River Somatostatin Product Portfolios and Specifications
13.10.3 Yangtze River Somatostatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Yangtze River Main Business Overview
13.10.5 Yangtze River Latest Developments
13.11 Siyao
13.11.1 Siyao Company Information
13.11.2 Siyao Somatostatin Product Portfolios and Specifications
13.11.3 Siyao Somatostatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Siyao Main Business Overview
13.11.5 Siyao Latest Developments
13.12 Shuangcheng
13.12.1 Shuangcheng Company Information
13.12.2 Shuangcheng Somatostatin Product Portfolios and Specifications
13.12.3 Shuangcheng Somatostatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Shuangcheng Main Business Overview
13.12.5 Shuangcheng Latest Developments
13.13 Hainan Zhonghe
13.13.1 Hainan Zhonghe Company Information
13.13.2 Hainan Zhonghe Somatostatin Product Portfolios and Specifications
13.13.3 Hainan Zhonghe Somatostatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Hainan Zhonghe Main Business Overview
13.13.5 Hainan Zhonghe Latest Developments
13.14 SL PHARM
13.14.1 SL PHARM Company Information
13.14.2 SL PHARM Somatostatin Product Portfolios and Specifications
13.14.3 SL PHARM Somatostatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 SL PHARM Main Business Overview
13.14.5 SL PHARM Latest Developments
13.15 Wuhan Hualong
13.15.1 Wuhan Hualong Company Information
13.15.2 Wuhan Hualong Somatostatin Product Portfolios and Specifications
13.15.3 Wuhan Hualong Somatostatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Wuhan Hualong Main Business Overview
13.15.5 Wuhan Hualong Latest Developments
13.16 Qingdao Guoda
13.16.1 Qingdao Guoda Company Information
13.16.2 Qingdao Guoda Somatostatin Product Portfolios and Specifications
13.16.3 Qingdao Guoda Somatostatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Qingdao Guoda Main Business Overview
13.16.5 Qingdao Guoda Latest Developments
13.17 Chengdu Shengnuo
13.17.1 Chengdu Shengnuo Company Information
13.17.2 Chengdu Shengnuo Somatostatin Product Portfolios and Specifications
13.17.3 Chengdu Shengnuo Somatostatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Chengdu Shengnuo Main Business Overview
13.17.5 Chengdu Shengnuo Latest Developments
13.18 Longjin
13.18.1 Longjin Company Information
13.18.2 Longjin Somatostatin Product Portfolios and Specifications
13.18.3 Longjin Somatostatin Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 Longjin Main Business Overview
13.18.5 Longjin Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Somatostatin Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Somatostatin Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 0.25mg/pcs
Table 4. Major Players of 0.75mg/pcs
Table 5. Major Players of 3mg/pcs
Table 6. Global Somatostatin Sales byType (2020-2025) & (K Pcs)
Table 7. Global Somatostatin Sales Market Share byType (2020-2025)
Table 8. Global Somatostatin Revenue byType (2020-2025) & ($ million)
Table 9. Global Somatostatin Revenue Market Share byType (2020-2025)
Table 10. Global Somatostatin Sale Price byType (2020-2025) & (USD/Pcs)
Table 11. Global Somatostatin Sale by Application (2020-2025) & (K Pcs)
Table 12. Global Somatostatin Sale Market Share by Application (2020-2025)
Table 13. Global Somatostatin Revenue by Application (2020-2025) & ($ million)
Table 14. Global Somatostatin Revenue Market Share by Application (2020-2025)
Table 15. Global Somatostatin Sale Price by Application (2020-2025) & (USD/Pcs)
Table 16. Global Somatostatin Sales by Company (2020-2025) & (K Pcs)
Table 17. Global Somatostatin Sales Market Share by Company (2020-2025)
Table 18. Global Somatostatin Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Somatostatin Revenue Market Share by Company (2020-2025)
Table 20. Global Somatostatin Sale Price by Company (2020-2025) & (USD/Pcs)
Table 21. Key Manufacturers Somatostatin Producing Area Distribution and Sales Area
Table 22. Players Somatostatin Products Offered
Table 23. Somatostatin Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Somatostatin Sales by Geographic Region (2020-2025) & (K Pcs)
Table 27. Global Somatostatin Sales Market Share Geographic Region (2020-2025)
Table 28. Global Somatostatin Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Somatostatin Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Somatostatin Sales by Country/Region (2020-2025) & (K Pcs)
Table 31. Global Somatostatin Sales Market Share by Country/Region (2020-2025)
Table 32. Global Somatostatin Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Somatostatin Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Somatostatin Sales by Country (2020-2025) & (K Pcs)
Table 35. Americas Somatostatin Sales Market Share by Country (2020-2025)
Table 36. Americas Somatostatin Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Somatostatin Sales byType (2020-2025) & (K Pcs)
Table 38. Americas Somatostatin Sales by Application (2020-2025) & (K Pcs)
Table 39. APAC Somatostatin Sales by Region (2020-2025) & (K Pcs)
Table 40. APAC Somatostatin Sales Market Share by Region (2020-2025)
Table 41. APAC Somatostatin Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Somatostatin Sales byType (2020-2025) & (K Pcs)
Table 43. APAC Somatostatin Sales by Application (2020-2025) & (K Pcs)
Table 44. Europe Somatostatin Sales by Country (2020-2025) & (K Pcs)
Table 45. Europe Somatostatin Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Somatostatin Sales byType (2020-2025) & (K Pcs)
Table 47. Europe Somatostatin Sales by Application (2020-2025) & (K Pcs)
Table 48. Middle East & Africa Somatostatin Sales by Country (2020-2025) & (K Pcs)
Table 49. Middle East & Africa Somatostatin Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Somatostatin Sales byType (2020-2025) & (K Pcs)
Table 51. Middle East & Africa Somatostatin Sales by Application (2020-2025) & (K Pcs)
Table 52. Key Market Drivers & Growth Opportunities of Somatostatin
Table 53. Key Market Challenges & Risks of Somatostatin
Table 54. Key IndustryTrends of Somatostatin
Table 55. Somatostatin Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Somatostatin Distributors List
Table 58. Somatostatin Customer List
Table 59. Global Somatostatin SalesForecast by Region (2026-2031) & (K Pcs)
Table 60. Global Somatostatin RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. Americas Somatostatin SalesForecast by Country (2026-2031) & (K Pcs)
Table 62. Americas Somatostatin Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APAC Somatostatin SalesForecast by Region (2026-2031) & (K Pcs)
Table 64. APAC Somatostatin Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. Europe Somatostatin SalesForecast by Country (2026-2031) & (K Pcs)
Table 66. Europe Somatostatin RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Somatostatin SalesForecast by Country (2026-2031) & (K Pcs)
Table 68. Middle East & Africa Somatostatin RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Global Somatostatin SalesForecast byType (2026-2031) & (K Pcs)
Table 70. Global Somatostatin RevenueForecast byType (2026-2031) & ($ millions)
Table 71. Global Somatostatin SalesForecast by Application (2026-2031) & (K Pcs)
Table 72. Global Somatostatin RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. Merck (Schweiz) AG Basic Information, Somatostatin Manufacturing Base, Sales Area and Its Competitors
Table 74. Merck (Schweiz) AG Somatostatin Product Portfolios and Specifications
Table 75. Merck (Schweiz) AG Somatostatin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 76. Merck (Schweiz) AG Main Business
Table 77. Merck (Schweiz) AG Latest Developments
Table 78. SANOFI-AVENTISFRANCE Basic Information, Somatostatin Manufacturing Base, Sales Area and Its Competitors
Table 79. SANOFI-AVENTISFRANCE Somatostatin Product Portfolios and Specifications
Table 80. SANOFI-AVENTISFRANCE Somatostatin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 81. SANOFI-AVENTISFRANCE Main Business
Table 82. SANOFI-AVENTISFRANCE Latest Developments
Table 83. Lyomark Pharma GmbH Basic Information, Somatostatin Manufacturing Base, Sales Area and Its Competitors
Table 84. Lyomark Pharma GmbH Somatostatin Product Portfolios and Specifications
Table 85. Lyomark Pharma GmbH Somatostatin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 86. Lyomark Pharma GmbH Main Business
Table 87. Lyomark Pharma GmbH Latest Developments
Table 88. ALFA WASSERMANN S.p.A. Basic Information, Somatostatin Manufacturing Base, Sales Area and Its Competitors
Table 89. ALFA WASSERMANN S.p.A. Somatostatin Product Portfolios and Specifications
Table 90. ALFA WASSERMANN S.p.A. Somatostatin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 91. ALFA WASSERMANN S.p.A. Main Business
Table 92. ALFA WASSERMANN S.p.A. Latest Developments
Table 93. Polypeptide Laboratories, Inc Basic Information, Somatostatin Manufacturing Base, Sales Area and Its Competitors
Table 94. Polypeptide Laboratories, Inc Somatostatin Product Portfolios and Specifications
Table 95. Polypeptide Laboratories, Inc Somatostatin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 96. Polypeptide Laboratories, Inc Main Business
Table 97. Polypeptide Laboratories, Inc Latest Developments
Table 98. SAMARTH Basic Information, Somatostatin Manufacturing Base, Sales Area and Its Competitors
Table 99. SAMARTH Somatostatin Product Portfolios and Specifications
Table 100. SAMARTH Somatostatin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 101. SAMARTH Main Business
Table 102. SAMARTH Latest Developments
Table 103. UBPL Basic Information, Somatostatin Manufacturing Base, Sales Area and Its Competitors
Table 104. UBPL Somatostatin Product Portfolios and Specifications
Table 105. UBPL Somatostatin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 106. UBPL Main Business
Table 107. UBPL Latest Developments
Table 108. HYBIO Basic Information, Somatostatin Manufacturing Base, Sales Area and Its Competitors
Table 109. HYBIO Somatostatin Product Portfolios and Specifications
Table 110. HYBIO Somatostatin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 111. HYBIO Main Business
Table 112. HYBIO Latest Developments
Table 113.TianTaiShan Basic Information, Somatostatin Manufacturing Base, Sales Area and Its Competitors
Table 114.TianTaiShan Somatostatin Product Portfolios and Specifications
Table 115.TianTaiShan Somatostatin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 116.TianTaiShan Main Business
Table 117.TianTaiShan Latest Developments
Table 118. Yangtze River Basic Information, Somatostatin Manufacturing Base, Sales Area and Its Competitors
Table 119. Yangtze River Somatostatin Product Portfolios and Specifications
Table 120. Yangtze River Somatostatin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 121. Yangtze River Main Business
Table 122. Yangtze River Latest Developments
Table 123. Siyao Basic Information, Somatostatin Manufacturing Base, Sales Area and Its Competitors
Table 124. Siyao Somatostatin Product Portfolios and Specifications
Table 125. Siyao Somatostatin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 126. Siyao Main Business
Table 127. Siyao Latest Developments
Table 128. Shuangcheng Basic Information, Somatostatin Manufacturing Base, Sales Area and Its Competitors
Table 129. Shuangcheng Somatostatin Product Portfolios and Specifications
Table 130. Shuangcheng Somatostatin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 131. Shuangcheng Main Business
Table 132. Shuangcheng Latest Developments
Table 133. Hainan Zhonghe Basic Information, Somatostatin Manufacturing Base, Sales Area and Its Competitors
Table 134. Hainan Zhonghe Somatostatin Product Portfolios and Specifications
Table 135. Hainan Zhonghe Somatostatin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 136. Hainan Zhonghe Main Business
Table 137. Hainan Zhonghe Latest Developments
Table 138. SL PHARM Basic Information, Somatostatin Manufacturing Base, Sales Area and Its Competitors
Table 139. SL PHARM Somatostatin Product Portfolios and Specifications
Table 140. SL PHARM Somatostatin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 141. SL PHARM Main Business
Table 142. SL PHARM Latest Developments
Table 143. Wuhan Hualong Basic Information, Somatostatin Manufacturing Base, Sales Area and Its Competitors
Table 144. Wuhan Hualong Somatostatin Product Portfolios and Specifications
Table 145. Wuhan Hualong Somatostatin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 146. Wuhan Hualong Main Business
Table 147. Wuhan Hualong Latest Developments
Table 148. Qingdao Guoda Basic Information, Somatostatin Manufacturing Base, Sales Area and Its Competitors
Table 149. Qingdao Guoda Somatostatin Product Portfolios and Specifications
Table 150. Qingdao Guoda Somatostatin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 151. Qingdao Guoda Main Business
Table 152. Qingdao Guoda Latest Developments
Table 153. Chengdu Shengnuo Basic Information, Somatostatin Manufacturing Base, Sales Area and Its Competitors
Table 154. Chengdu Shengnuo Somatostatin Product Portfolios and Specifications
Table 155. Chengdu Shengnuo Somatostatin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 156. Chengdu Shengnuo Main Business
Table 157. Chengdu Shengnuo Latest Developments
Table 158. Longjin Basic Information, Somatostatin Manufacturing Base, Sales Area and Its Competitors
Table 159. Longjin Somatostatin Product Portfolios and Specifications
Table 160. Longjin Somatostatin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 161. Longjin Main Business
Table 162. Longjin Latest Developments
LIST OFFIGURES
Figure 1. Picture of Somatostatin
Figure 2. Somatostatin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Somatostatin Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Somatostatin Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Somatostatin Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Somatostatin Sales Market Share by Country/Region (2024)
Figure 10. Somatostatin Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 0.25mg/pcs
Figure 12. Product Picture of 0.75mg/pcs
Figure 13. Product Picture of 3mg/pcs
Figure 14. Global Somatostatin Sales Market Share byType in 2025
Figure 15. Global Somatostatin Revenue Market Share byType (2020-2025)
Figure 16. Somatostatin Consumed in Hormonal Disorder
Figure 17. Global Somatostatin Market: Hormonal Disorder (2020-2025) & (K Pcs)
Figure 18. Somatostatin Consumed in Oncology
Figure 19. Global Somatostatin Market: Oncology (2020-2025) & (K Pcs)
Figure 20. Somatostatin Consumed in Metabolic Disorder
Figure 21. Global Somatostatin Market: Metabolic Disorder (2020-2025) & (K Pcs)
Figure 22. Somatostatin Consumed in Others
Figure 23. Global Somatostatin Market: Others (2020-2025) & (K Pcs)
Figure 24. Global Somatostatin Sale Market Share by Application (2024)
Figure 25. Global Somatostatin Revenue Market Share by Application in 2025
Figure 26. Somatostatin Sales by Company in 2025 (K Pcs)
Figure 27. Global Somatostatin Sales Market Share by Company in 2025
Figure 28. Somatostatin Revenue by Company in 2025 ($ millions)
Figure 29. Global Somatostatin Revenue Market Share by Company in 2025
Figure 30. Global Somatostatin Sales Market Share by Geographic Region (2020-2025)
Figure 31. Global Somatostatin Revenue Market Share by Geographic Region in 2025
Figure 32. Americas Somatostatin Sales 2020-2025 (K Pcs)
Figure 33. Americas Somatostatin Revenue 2020-2025 ($ millions)
Figure 34. APAC Somatostatin Sales 2020-2025 (K Pcs)
Figure 35. APAC Somatostatin Revenue 2020-2025 ($ millions)
Figure 36. Europe Somatostatin Sales 2020-2025 (K Pcs)
Figure 37. Europe Somatostatin Revenue 2020-2025 ($ millions)
Figure 38. Middle East & Africa Somatostatin Sales 2020-2025 (K Pcs)
Figure 39. Middle East & Africa Somatostatin Revenue 2020-2025 ($ millions)
Figure 40. Americas Somatostatin Sales Market Share by Country in 2025
Figure 41. Americas Somatostatin Revenue Market Share by Country (2020-2025)
Figure 42. Americas Somatostatin Sales Market Share byType (2020-2025)
Figure 43. Americas Somatostatin Sales Market Share by Application (2020-2025)
Figure 44. United States Somatostatin Revenue Growth 2020-2025 ($ millions)
Figure 45. Canada Somatostatin Revenue Growth 2020-2025 ($ millions)
Figure 46. Mexico Somatostatin Revenue Growth 2020-2025 ($ millions)
Figure 47. Brazil Somatostatin Revenue Growth 2020-2025 ($ millions)
Figure 48. APAC Somatostatin Sales Market Share by Region in 2025
Figure 49. APAC Somatostatin Revenue Market Share by Region (2020-2025)
Figure 50. APAC Somatostatin Sales Market Share byType (2020-2025)
Figure 51. APAC Somatostatin Sales Market Share by Application (2020-2025)
Figure 52. China Somatostatin Revenue Growth 2020-2025 ($ millions)
Figure 53. Japan Somatostatin Revenue Growth 2020-2025 ($ millions)
Figure 54. South Korea Somatostatin Revenue Growth 2020-2025 ($ millions)
Figure 55. Southeast Asia Somatostatin Revenue Growth 2020-2025 ($ millions)
Figure 56. India Somatostatin Revenue Growth 2020-2025 ($ millions)
Figure 57. Australia Somatostatin Revenue Growth 2020-2025 ($ millions)
Figure 58. ChinaTaiwan Somatostatin Revenue Growth 2020-2025 ($ millions)
Figure 59. Europe Somatostatin Sales Market Share by Country in 2025
Figure 60. Europe Somatostatin Revenue Market Share by Country (2020-2025)
Figure 61. Europe Somatostatin Sales Market Share byType (2020-2025)
Figure 62. Europe Somatostatin Sales Market Share by Application (2020-2025)
Figure 63. Germany Somatostatin Revenue Growth 2020-2025 ($ millions)
Figure 64.France Somatostatin Revenue Growth 2020-2025 ($ millions)
Figure 65. UK Somatostatin Revenue Growth 2020-2025 ($ millions)
Figure 66. Italy Somatostatin Revenue Growth 2020-2025 ($ millions)
Figure 67. Russia Somatostatin Revenue Growth 2020-2025 ($ millions)
Figure 68. Middle East & Africa Somatostatin Sales Market Share by Country (2020-2025)
Figure 69. Middle East & Africa Somatostatin Sales Market Share byType (2020-2025)
Figure 70. Middle East & Africa Somatostatin Sales Market Share by Application (2020-2025)
Figure 71. Egypt Somatostatin Revenue Growth 2020-2025 ($ millions)
Figure 72. South Africa Somatostatin Revenue Growth 2020-2025 ($ millions)
Figure 73. Israel Somatostatin Revenue Growth 2020-2025 ($ millions)
Figure 74.Turkey Somatostatin Revenue Growth 2020-2025 ($ millions)
Figure 75. GCC Countries Somatostatin Revenue Growth 2020-2025 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Somatostatin in 2025
Figure 77. Manufacturing Process Analysis of Somatostatin
Figure 78. Industry Chain Structure of Somatostatin
Figure 79. Channels of Distribution
Figure 80. Global Somatostatin Sales MarketForecast by Region (2026-2031)
Figure 81. Global Somatostatin Revenue Market ShareForecast by Region (2026-2031)
Figure 82. Global Somatostatin Sales Market ShareForecast byType (2026-2031)
Figure 83. Global Somatostatin Revenue Market ShareForecast byType (2026-2031)
Figure 84. Global Somatostatin Sales Market ShareForecast by Application (2026-2031)
Figure 85. Global Somatostatin Revenue Market ShareForecast by Application (2026-2031)
